ArticleInsights into imaging2026
Radiologists' memory as a data protection risk: a worst-case stress test for chest radiograph re-identification.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo estimate an upper bound of memory-based re-identification risk for chest radiographs by testing radiologists under conditions that favor recognition. MATERIALS AND
methodsIn this prospective, multicenter, web-based reader study, radiologists from 38 centers completed two reading phases. In Phase 1, each reader interpreted ten chest radiographs. After a minimum interval of 24 h, Phase 2 included six follow-up target examinations and six new non-target examinations (50% target prevalence). After each Phase-2 examination, readers indicated whether they remembered the patient. Following a positive response, they were asked separately whether they remembered the Phase-1 pseudonym and/or case position. Thirty-three readers with fully classifiable Phase-2 data contributed 396 Phase-2 examinations to the predefined primary analysis.
resultsReaders answered "remember" in 139 of 396 examinations (35.1%). Sensitivity for repeated target examinations was 50.0% (99/198), whereas 20.2% of new non-target examinations were nevertheless judged as remembered (40/198). Explicit identifiers were attempted in 23 of 396 examinations (5.8%). At least one explicit identifier, defined as the Phase-1 pseudonym and/or case position, was correct in five of 396 examinations (1.3%). In a low-prevalence model with one known patient per dataset, the positive predictive value of a "remember" response decreased from 2.44% in datasets of 100 radiographs to 0.25% in datasets of 1000 radiographs.
conclusionsEven in a design that favored memory, correct recall of explicit identifiers was rare, whereas false-positive recognition remained common. These findings support treating radiologists' memory as a limited, upper-bound component of re-identification risk, rather than assuming that familiarity routinely translates into identification. CRITICAL RELEVANCE STATEMENT: Even under conditions deliberately favoring memory, radiologists rarely converted familiarity with prior chest radiographs into correct explicit identifiers; in low-prevalence datasets, false-positive recognition dominated the practical meaning of a "remember" judgment. KEY POINTS: How often does a radiologist's feeling of familiarity with a previously seen chest radiograph translate into correct recall of a usable explicit identifier? In a deliberately memory-favoring design, sensitivity was 50.0%, but 20.2% of new examinations were false positives and only 1.3% yielded a correct explicit identifier.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.